Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Le Guellec

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Therapie|June 4, 2011
[Level of evidence for therapeutic drug monitoring of fluconazole]Nicolas Venisse, Chantal Le Guellec
Therapie|August 12, 2010
[Therapeutic drug monitoring of 5-fluorouracil after its administration in high-dose protocols]Michèle Boisdron-Celle, Chantal Le Guellec,
Therapie|May 7, 2010
[Therapeutic drug monitoring]Chantal Le Guellec, Danièle Bentué-Ferrer,
Therapie|July 10, 2016
[Not Available]Michèle Boisdron-Celle, Chantal Le Guellec,
Therapie|April 7, 2011
[Level of evidence for therapeutic drug monitoring of teicoplatin]Audrey Boulamery, Nicolas Venisse, Chantal Le Guellec, et al.
Therapie|July 10, 2016
[Not Available]Audrey Boulamery, Nicolas Venisse, Chantal Le Guellec, et al.
Therapie|July 10, 2016
[Not Available]Anne Hulin, Eric Dailly, Chantal Le Guellec, et al.
Therapie|June 4, 2011
[Level of evidence for therapeutic drug monitoring of voriconazole]Anne Hulin, Eric Dailly, Chantal Le Guellec, et al.
Therapie|August 12, 2010
[Therapeutic drug monitoring of tyrosine-kinase inhibitors in the treatment of chronic myelogenous leukaemia: interests and limits]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapie|August 12, 2010
[Level of evidence for therapeutic drug monitoring of carboplatin]Anne Hulin, Etienne Chatelut, Bernard Royer, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Therapie|June 4, 2011
[Level of evidence for therapeutic drug monitoring of fluconazole]Nicolas Venisse, Chantal Le Guellec
Therapie|August 12, 2010
[Therapeutic drug monitoring of 5-fluorouracil after its administration in high-dose protocols]Michèle Boisdron-Celle, Chantal Le Guellec,
Therapie|May 7, 2010
[Therapeutic drug monitoring]Chantal Le Guellec, Danièle Bentué-Ferrer,
Therapie|July 10, 2016
[Not Available]Michèle Boisdron-Celle, Chantal Le Guellec,
Therapie|April 7, 2011
[Level of evidence for therapeutic drug monitoring of teicoplatin]Audrey Boulamery, Nicolas Venisse, Chantal Le Guellec, et al.
Therapie|July 10, 2016
[Not Available]Audrey Boulamery, Nicolas Venisse, Chantal Le Guellec, et al.
Therapie|July 10, 2016
[Not Available]Anne Hulin, Eric Dailly, Chantal Le Guellec, et al.
Therapie|June 4, 2011
[Level of evidence for therapeutic drug monitoring of voriconazole]Anne Hulin, Eric Dailly, Chantal Le Guellec, et al.
Therapie|August 12, 2010
[Therapeutic drug monitoring of tyrosine-kinase inhibitors in the treatment of chronic myelogenous leukaemia: interests and limits]Stéphane Bouchet, Bernard Royer, Chantal Le Guellec, et al.
Therapie|August 12, 2010
[Level of evidence for therapeutic drug monitoring of carboplatin]Anne Hulin, Etienne Chatelut, Bernard Royer, et al.
Pageof 6